High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea · Delayed Price · Currency is KRW

10,680

+340 (3.29%)

At close: Jul 31, 2026

High Tech Pharm Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	69,050	70,183	77,513	76,772	102,947	73,287
Revenue Growth	-6.15%	-9.46%	0.97%	-25.43%	40.47%	-1.58%
Gross Profit	15,911	16,937	19,481	12,834	7,770	3,071
Operating Income	9,198	12,856	15,558	10,089	4,927	-412.02
Net Income	9,024	11,475	13,710	8,076	5,873	-1,225
Earnings Per Share	843.31	1072.37	1289.43	1139.33	552.32	-115.24
EPS Growth	-28.99%	-16.83%	13.17%	106.28%	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	8,474	14,430	7,759	5,365	7,880	12,637
Total Debt	27.13	33.61	8,002	16,500	16,424	15,978
Net Cash (Debt)	8,447	14,396	-243.03	-11,135	-8,543	-3,340
Net Cash Growth	11.23%	-	-	-	-	-
Net Cash Per Share	789.38	1345.34	-22.86	-1570.78	-803.46	-314.15

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	3,883	17,028	14,691	2,909	-3,703	6,928
Capital Expenditures	-1,853	-1,926	-2,133	-5,091	-655.97	-859.6
Free Cash Flow	2,030	15,102	12,558	-2,183	-4,359	6,068
Free Cash Flow Growth	-79.48%	20.25%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	23.04%	24.13%	25.13%	16.72%	7.55%	4.19%
Operating Margin	13.32%	18.32%	20.07%	13.14%	4.79%	-0.56%
Pretax Margin	15.75%	19.70%	22.04%	12.85%	3.91%	-1.18%
Profit Margin	13.07%	16.35%	17.69%	10.52%	5.71%	-1.67%
FCF Margin	2.94%	21.52%	16.20%	-2.84%	-4.23%	8.28%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.42	11.14	10.86	12.28	13.16	-
P/FCF Ratio	54.83	8.46	11.85	-	-	16.00
PS Ratio	1.61	1.82	1.92	1.29	0.75	1.33